McMaster University engineers have devised a way to make testing for new drugs more efficient and affordable, and reduce the time for helpful medications to reach the public
Chemical Engineering Associate Professor Todd Hoare and Rabia Mateen, a PhD candidate in Biomedical Engineering, have created a printed paper-based device that can speed up and improve the accuracy of the drug screening process. Their work, which could also be used to diagnose diseases, identify environmental contaminants and pinpoint biological warfare agents, was published in Nature Communications in February.
Currently, drug testing is done in multiple stages, with the first stage involving testing thousands of drug candidates in rapid succession to see how well they bind, block or degrade a molecule of interest to the target disease. Subsequent stages involve more extensive testing of drugs that show promise in this first step.
However, the way this initial first screen is now done results in many inaccurate results, with as many as 95% of drug candidates having no chance of becoming a useful drug. In most cases, these inaccuracies arise from the candidate drugs sticking together during the screen to create particles that physically, instead of chemically, block the activity of the molecule targeted by the drug. Such inaccuracies are only now discovered in the slower and more expensive second stage of screening, resulting in significant time and money wasted during the drug discovery process.
Hoare and Mateen have come up with a way to improve the first stage of testing by using a new printable hydrogel, a network of polymers used in everything from contact lenses to disposable diapers. The thin layers of printed hydrogels can form a cage around the target molecule so drug particles formed can’t access the target molecule and trigger the inaccurate result. Instead, only drugs that chemically bind to the target molecule (the ones that could become practical drugs) are allowed into the hydrogel to give a positive result. The printed device developed is inexpensive and can be used directly in drug screening, improving accuracy without requiring a significant change in how drug screening is now done. As an added benefit, the same sensitivity can be achieved using much less sample volume, further reducing the cost of the screen.
“We had already developed the printing method, but were not sure what to do with the materials,” Mateen said. “Reading about this significant issue in the area of drug screening made me realize that these materials could directly address this problem in a simple and effective way.”
The researchers expect this to make testing more affordable and to speed up the discovery of new drugs. In addition, to help address the surge of antibiotic resistance, the technology can also help to more quickly identify “helper drugs” that can make even drug-resistant bacteria susceptible to our current antibiotics.
“As the next step, we are looking for industry partners to prove the effectiveness of our technology on a full-scale screen of thousands of molecules that can help to extend the lifetime of our current antibiotics,” Hoare said. “We are optimistic this approach can help to bring new effective drugs to patients faster than is currently possible”.
The Latest on: Drug discovery
Using Deep Neural Network Acceleration for Image Analysis in Drug Discovery
on May 23, 2018 at 10:55 am
What’s New: Intel collaborates with Novartis* on the use of deep neural networks (DNN) to accelerate high content screening – a key element of early drug discovery. The collaboration team cut time to train image analysis models from 11 hours to 31 ... […]
Research report explores the drug discovery informatics market to represent a significant expansion at CAGR +16% during forecast period
on May 19, 2018 at 4:49 pm
Drug discovery informatics is a complex process that requires the generation of very large information, and data. Through application of modern computational, and engineering approaches the models are simulated, analyzed, and visualized. A study of ... […]
FDA just approved the first drug to prevent migraines. Here’s the story of its discovery—and its limitations
on May 18, 2018 at 9:18 am
*Update, 18 May, 10 a.m.: Yesterday, the U.S. Food and Drug Administration approved the first in a new class of drugs designed to prevent migraines. This feature, originally published on 8 January 2016, describes the history of these drugs, the powerful ... […]
Drug Discovery Informatics Market Is Anticipated to Register CAGR of over 17.0% from 2017 to 2025
on May 18, 2018 at 4:04 am
Albany, NY -- (SBWIRE) -- 05/18/2018 -- The global drug discovery informatics market was valued approximately US$ 2.0 Bn in 2016 and is anticipated to register CAGR of over 17.0% from 2017 to 2025 to reach value of approximately US$ 7.8 Bn by 2025 ... […]
From lab to pharmacy: IU researchers' discovery leads to new drug to treat rare bone disease
on May 18, 2018 at 3:27 am
From lab to pharmacy: IU researchers' discovery leads to new drug to treat rare bone disease IU researchers play a pivotal role in development of first successful drug to treat rare genetic bone condition, XLH. Check out this story on IndyStar.com: https ... […]
Developing a High Throughput Mass Spectrometry Platform for Drug Discovery
on May 18, 2018 at 2:43 am
Your presentation at Pittcon 2018 focussed on Mass Spectroscopy (MS) based high-throughput screening for drug discovery. What are the current challenges associated with screen samples? Acoustic mass spectrometry offers us the ability to screen very, very ... […]
Discovery will impact design of drug delivery systems at the molecular level
on May 17, 2018 at 7:12 am
Alessandro Grattoni, Ph.D., is one of the architects behind a nanochannel drug-delivery system that acts as a filter with hundreds of thousands of uniform nanoscale channels. His lab develops these implantable systems for controlled drug delivery to treat ... […]
3 Day Conference: Drug Discovery and Therapy World Congress 2019 - Academic (Boston, United States - September 3-5, 2019) - ResearchAndMarkets.com
on May 16, 2018 at 6:10 am
DUBLIN--(BUSINESS WIRE)--May 16, 2018--The "Drug Discovery and Therapy World Congress 2019 - Academic" conference has been added to ResearchAndMarkets.com's offering. This conference will host leading scientists from the academia and industry worldwide, to ... […]
Drug Discovery Services Market 2018 Germinating at CAGR 10.8%: By Drug Type; Small Molecule Drug, Biologics and Forecast Up to 2023
on May 14, 2018 at 11:31 am
The Drug Discovery Services Market report provide country level analysis of the market with respect to the current market size and future growth prospect. The report gives overview of key players and their strategic profiling in the market, comprehensively ... […]
Drug Discovery Informatics Market 2018 Latest Study On Segmentation Analysis, Leading Players and Industry Trends Forecast to 2025
on May 11, 2018 at 1:35 am
The Insight partners has announced the addition of the Drug Discovery Informatics Market to 2025 - Global Analysis and Forecasts by Type, Application, Deployment type and Industry Vertical report to their offering. (EMAILWIRE.COM, May 11, 2018 ) Drug ... […]
via Google News and Bing News